Journal of the Association of Physicians of India
December 1, 2022
Gouranga Santra
18 citations
INTRODUCTION: Growing evidences of the health benefits of yoga are available in the literature. But physicians are not aware of it. METHODOLOGY: Databases like PubMed, PubMed Central, Google Scholar, and Scopus are searched for the articles on preventive, therapeutic, and rehabilitation potential of yoga. Scientific evidences available are analyzed and incorporated into the article. RESULT:...
Journal of Network Security Computer Networks
November 21, 2022
D Shreya Jingade, R Ashok Kumar, K. Vijayalakshmi et al.
Through meditation, one can acquire a calm, awake state of mind. It can assist people in becoming more conscious of themselves and their surroundings. Pain, worry, and other undesirable feelings may be significantly reduced with meditation. EEG is now one of the methods widely employed in the field of neuroscience to study how the brain works. Different capabilities of the brain are identified...
Research Square
November 15, 2022
Kennedy Robertson, Ian Gold, Samuel P. L. Veissière et al.
preprint
Abstract Purpose: Delusional ideation, defined as false beliefs and altered thinking, has long been attributed to anomalous/bizarre perceptual experiences and reasoning deficits. Recent studies, however, have challenged this view, suggesting instead that delusional ideation may have more of a social component to its phenomenology and underlying mechanisms. This study investigated associations...
The Journal of Clinical Psychiatry
November 14, 2022
Anna Feeney, Bettina B. Hoeppner, Marlene P. Freeman et al.
9 citations
Objective: Ketamine is a novel and rapidly acting treatment for major depressive disorder (MDD). Benzodiazepines are commonly coprescribed with antidepressants in MDD. This study sought to examine data from a randomized clinical trial that compared a single infusion of intravenous (IV) ketamine to midazolam placebo in treatment-resistant depression (DSM-IV-TR MDD) and to assess whether the use...
Pharmaceuticals
November 9, 2022
Sabrina de Carvalho Cartágenes, Cinthia Cristina Sousa de Menezes Da Silveira, Bruno Gonçalves Pinheiro et al.
Ketamine, also called 'K-powder' by abusers, an analog of phencyclidine, primarily acts as an antagonist of N-methyl-D-aspartic acid (NMDA) receptors, therapeutically used as an anesthetic agent. Ketamine also stimulates the limbic system, inducing hallucinations and dissociative effects. At sub-anesthetic doses, ketamine also displays hallucinatory and dissociative properties, but not loss of...
Palliative & Supportive Care
November 3, 2022
Lisa Reynolds, Brian S. Barnett, Jeremy Weleff et al.
19 citations
Abstract Objectives A resurgence of research investigating the administration of psychedelic compounds alongside psychotherapy suggests that this treatment is a promising intervention for anxiety, depression, and existential distress in people with cancer. However, psychedelic treatment that induces a mind-altering experience potentially poses barriers to vulnerable cancer patients, and...
Current Psychiatry Reports
November 2022
Allie L Peters, William J. Saunders, Melinda L. Jackson
To review the recent literature on mindfulness-based strategies for improving self-report and objective measures of sleep, in individuals with psychiatric disorders. Currently, research provides some support for the use of mindfulness-based interventions to improve sleep amongst individuals with psychiatric comorbidities. The strongest evidence was for the use of standardized programs,...
International Journal of Surgery Global Health
November 1, 2022
Hamna Raheel, Unaiza Naeem, Asim Shaikh et al.
Mental health disorders such as depression and anxiety are major contributors to the overall global health burden. COVID-19 has further aggravated mental health disorders and also increased substance abuse due to lockdowns1. The Global Burden of Disease reported that the pandemic has led to a 27.6% increase in cases of major depressive disorder (MDD) and a 25.6% increase in cases of anxiety...
Cureus
November 1, 2022
Ricardo Irizarry, Amelia Winczura, Omar Dimassi et al.
26 citations
Psilocybin is an emerging potential therapy for the treatment of psychiatric illnesses. Microdosing has been shown to result in an overall improvement in patients with anxiety, depression, obsessive-compulsive disorder, post-traumatic stress disorder, and substance abuse. This meta-analysis explores and compiles prior research to make further inferences regarding psilocybin and its use for the...
October 26, 2022
George Danias, Jacob Appel
BACKGROUND Psychedelic substances have demonstrated promise in the treatment of depression, anxiety, and substance use disorders. Significant media coverage has been dedicated to psychedelic medicine, but it is unclear whether the public associates psilocybin with its potential therapeutic benefits. The COVID-19 pandemic led to an increase in depression, anxiety, and substance abuse in the...